Skip to content
★ Sign in to follow
VP

Vincent P. Ippolito

Executive
Anacor Pharmaceuticals, Inc.Medicis Pharmaceutical Corp
Total declarations
55
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (17 ops.)
€7.9M

Latest filing published 24 Jun 2016 for Anacor Pharmaceuticals, Inc., €6.0M.

Insider track record

Disclosed buys
0
Disclosed sells
17
Signal history

Vincent P. Ippolito: trading record in brief

Filings by Vincent P. Ippolito span 2 companies, the busiest being Medicis Pharmaceutical Corp and Anacor Pharmaceuticals, Inc. Between 4 April 2008 and 24 June 2016, the trades on record add up to 55 filings.

The open-market record consists of 17 sales worth €7.9M, with no purchase. Outside the open market, there are 31 share grants and 5 option exercises. 2016 to date brings no purchases and 11 sales.

Most recently, on 24 June 2016, the filings show a transaction worth €6.0M in Anacor Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Vincent P. Ippolito

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations54 total

25 of 54 declarations